A Single-center, Prospective, Cohort Study of the Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield Stent Implantation for Intracranial Aneurysms

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The objective of this study was to evaluate the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

⁃ Patients with unruptured intracranial aneurysms who received the intracranial Pipeline Flex with Shield stent.

⁃ Vascular conditions:

‣ 1\) There was no obvious calcification and stenosis of the parent artery. 2) The curvature of the bearing artery is minimal. 3) The parent artery diameter ≥2.5mm

• According to the committee's assessment, only one Pipeline flex with shield is needed for aneurysm treatment.

• Before the stent implantation procedure, standard dual antiplatelet therapy should be administered for at least 3 days.

• Patients with an Modified Rankin Scale(mRS) score of less than 2 on the day of registration.

• The operation was successful, and immediate postoperative angiography indicated good wall apposition.

Locations
Other Locations
China
Xuanwu Hospital, Capital Medical University
RECRUITING
Beijing
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 165
Related Therapeutic Areas
Sponsors
Leads: Xuanwu Hospital, Beijing

This content was sourced from clinicaltrials.gov